闵翼, 赵俊, 冯凡超, 张金荣, 殷智, 周同鑫. 基于文献计量学分析中医药治疗肺纤维化的研究现状及热点[J]. 职业卫生与应急救援, 2023, 41(5): 618-622. DOI: 10.16369/j.oher.issn.1007-1326.2023.05.019
引用本文: 闵翼, 赵俊, 冯凡超, 张金荣, 殷智, 周同鑫. 基于文献计量学分析中医药治疗肺纤维化的研究现状及热点[J]. 职业卫生与应急救援, 2023, 41(5): 618-622. DOI: 10.16369/j.oher.issn.1007-1326.2023.05.019
shu
MIN Yi, ZHAO Jun, FENG Fanchao, ZHANG Jinrong, YIN zhi, ZHOU Tongxin. Research status and hotspots of traditional Chinese medicine in treatment of pulmonary fibrosis: based on bibliometric analysis[J]. Occupational Health and Emergency Rescue, 2023, 41(5): 618-622. DOI: 10.16369/j.oher.issn.1007-1326.2023.05.019
Citation: MIN Yi, ZHAO Jun, FENG Fanchao, ZHANG Jinrong, YIN zhi, ZHOU Tongxin. Research status and hotspots of traditional Chinese medicine in treatment of pulmonary fibrosis: based on bibliometric analysis[J]. Occupational Health and Emergency Rescue, 2023, 41(5): 618-622. DOI: 10.16369/j.oher.issn.1007-1326.2023.05.019
shu

基于文献计量学分析中医药治疗肺纤维化的研究现状及热点

Research status and hotspots of traditional Chinese medicine in treatment of pulmonary fibrosis: based on bibliometric analysis

    摘要
  • 摘要:
      目的  总结中医药治疗肺纤维化(pulmonary fibrosis, PF)的研究进展以及研究热点, 为中医药治疗肺纤维化研究提供借鉴意义。
      方法  通过文献检索, 选取1995年1月1日—2023年1月1日收录于中国知网(CNKI)的相关文献, 利用VOSviewer软件对其进行文献可视化分析, 并提出当前与未来可能的研究热点与方向。
      结果  共纳入与中医药治疗肺纤维化相关的文献共794篇。中医药在治疗肺纤维化领域的关注度呈逐年上升的趋势, 2020年发文数量达到顶峰。北京中医药大学的相关研究最多。频次排名前10的关键词分别为特发性肺间质纤维化(375次)、肺纤维化(314次)、中医药(262次)、临床研究(58次)、病因病机(55次)、博来霉素(40次)、转化生长因子-β(TGF-β)(28次)、肺痿(31次)、上皮间质转化(26次)、补阳还五汤(26次)。近3年来, 中医药领域对肺纤维化治疗方向大致从中药复方向单味中药转变。中医药治疗肺纤维化的研究重心在病因、病机与临床研究等领域。
      结论  中医药治疗肺纤维化的认可度逐渐上升。相关研究已经向单味中药转变。

     

    Abstract:
      Objective  To summarize the research progress and hotspots of traditional Chinese medicine(TCM) in the treatment of pulmonary fibrosis(PF) and provide references for future research.
      Methods  Literature regarding TCM treatment for PF retrieved in the CNKI database from January 1, 1995 to January 1, 2023 was selected. The VOS viewer was utilized to conduct visualized analysis, and current and future potential hotspots and directions were proposed.
      Results  A total of 794 related papers were included. The number of articles on TCM for treating PF showed an upward trend annually, peaking in 2020. Beijing University of Chinese Medicine published the most papers in this field. The top 10 keywords were idiopathic pulmonary fibrosis(375 times), pulmonary fibrosis(314 times), TCM(262 times), clinical research(58 times), pathogenesis(55 times), bleomycin(40 times), TGF-β(28 times), atrophic lung disease(31 times), epithelial-mesenchymal transition(26 times), and Buyang Huanwu Decoction(26 times). In the past 3 years, the treatment direction has shifted from TCM formula to single herbs. The research focus of traditional Chinese medicine in the treatment of pulmonary fiber is in the fields of etiology, pathogenesis, and clinical research.
      Conclusions  Recognition of TCM in treating PF is gradually increasing. Related research has transformed to focus more on single Chinese herbs.

     

    • HTML全文
    • 参考文献(22)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回